Product Specification

Explore our Product Specification, including key quality parameters, physical and chemical characteristics, composition and much more.

Select desired Product Specification:

Pharmaquinone^® 5% MCT Oil

Ref. no. SPK/KJ/004

Rev. 08

Date: 16.04 .2025

Product name

Pharmaquinone^® 5% MCT Oil Vitamin K2 as MK-7

SKU code

500L

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

100% Organic Coconut Oil [MCT)

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

General information

Synthetic Vitamin K2 as all-trans MK-7 diluted in medium chain triglyceride (MCT) oil from coconuts for use in food and dietary supplements.

Country of origin

Poland

Shelf-life

36 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. Partial crystallization may occur at lower temperature. Protect from light. After opening, store in the original closed container.

Packaging

1 kg (500L1) or 5 kg (500L5) of the product in aluminum bottle

Tests

Requirements

Method

Description

Light yellow to yellow oil

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/009

Vitamin K2 (as all-trans MK7) assay

> 5.0% or > 50 000ppm

UPLC method*/USP method**
ANL/KJ/009

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/009

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/009

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/009

Density (in 20˚C)

0.930-0.960 g/ml

PN-EN ISO 6883:2017-03

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 1% MCT Oil

Ref. no. SPK/KJ/003

Rev. 07

Date: 16.04 .2025

Product name

Pharmaquinone^® 1% MCT Oil Vitamin K2 as MK-7

SKU code

100L

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

100% Organic Coconut Oil [MCT)

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

General information

Synthetic Vitamin K2 as all-trans MK-7 diluted in medium chain triglyceride (MCT) oil from coconuts for use in food and dietary supplements.

Country of origin

Poland

Shelf-life

36 months from manufacture

Storage conditions

Packaging

1 kg (100L1) or 5 kg (100L5) of the product in aluminum bottle

Tests

Requirements

Method

Description

Light yellow to yellow oil

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/009

Vitamin K2 (as all-trans MK7) assay

> 1.0% or > 10 000ppm

UPLC method*/USP method**
ANL/KJ/009

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/009

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/009

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/009

Density (in 20˚C)

0.930-0.960 g/ml

PN-EN ISO 6883:2017-03

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2022>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 0.45% Olive Oil

Ref. no. SPK/KJ/008

Rev. 06

Date: 16.04 .2025

Product name

Pharmaquinone^® 0.45% Olive Oil Vitamin K2 as MK-7

SKU code

045L

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

Olive Oil

CAS number

Menaquinone-7

2124-57-4

Olive Oil

8001-25-0

General information

Synthetic vitamin K2 diluted in olive oil solution for use in food and dietary supplements

Country of origin

Poland

Shelf-life

18 months from manufacture

Storage conditions

Packaging

1 kg (045L1) or 5 kg (045L5) of the product in aluminum bottle with tamper evident PP screw cap closure with foam/aluminum liner and LDPE plug.

Tests

Requirements

Method

Description

Yellow to light green oil

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

USP method*

Vitamin K2 (as all-trans MK7) assay

≥ 0.45% to ≤ 0.54% or
≥ 4500 ppm to ≤ 5400 ppm

USP method*

Limit of Menaquinone-6

Absent

USP method*

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method*

Density (in 20˚C)

0.870-0.960 g/ml

PN-EN ISO 6883:2017-03

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>

*in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 0.15% MCT Oil

Ref. no. SPK/KJ/002

Rev. 07

Date: 16.04 .2025

Product name

Pharmaquinone^® 0.15% MCT Oil Vitamin K2 as MK-7

SKU code

015L

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

100% Organic Coconut Oil [MCT)

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

General information

Synthetic Vitamin K2 as all-trans MK-7 diluted in medium chain triglyceride (MCT) oil from coconuts for use in food and dietary supplements.

Country of origin

Poland

Shelf-life

36 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. Protect from light. After opening, store in the original closed container.

Packaging

1 kg (015L1) or 5 kg (015L5) of the product in aluminum bottle

Tests

Requirements

Method

Description

Light yellow oil

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/009

Vitamin K2 (as all-trans MK7) assay

> 0.15% or > 1500ppm

UPLC method*/USP method**
ANL/KJ/009

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/009

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/009

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/009

Density (in 20˚C)

0.930-0.960 g/ml

PN-EN ISO 6883:2017-03

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 1% MCC Powder

Ref. no. SPK/KJ/006

Rev. 08

Date: 16.04 .2025

Product name

Pharmaquinone^® 1% MCC Powder Vitamin K2 as MK-7

SKU code

100P

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

MCC Powder

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

MCC powder

9004-34-6

General information

Synthetic vitamin K2 diluted in oil solution and deposited on the microcrystalline cellulose for use in food and dietary supplements

Country of origin

Poland

Shelf-life

36 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. Protect from light. After opening, store in the original closed container.

Packaging

1 kg (100P1), 5 kg (100P5) or 20 kg (100P20) of the product in doypack with zipper bag

Tests

Requirements

Method

Description

Light yellow powder

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/010

Vitamin K2 (as all-trans MK7) assay

> 1.0% or > 10 000ppm

UPLC method*/USP method**
ANL/KJ/010

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/010

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/010

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/010

Particle size

> 90% passes through 40 mesh

PB-264 rev.1*

Bulk density

0.30-0.55 g/ml

Ph. Eur. <2.9.34> / USP <616>

Loss on drying

≤ 5.0%

Ph. Eur. <2.2.32> /USP<713>

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 0.25% MCC Powder

Ref. no. SPK/KJ/018

Rev. 03

Date: 16.04 .2025

Product name

Pharmaquinone^® 0.25% MCC Powder Vitamin K2 as MK-7

SKU code

025P

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

MCC Powder

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

MCC powder

9004-34-6

General information

Synthetic vitamin K2 diluted in oil solution and deposited on the microcrystalline cellulose for use in food and dietary supplements

Country of origin

Poland

Shelf-life

36 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. Protect from light. After opening, store in the original closed container.

Packaging

1 kg (025P1) or 5 kg (025P5) of the product in doypack with zipper bag

Tests

Requirements

Method

Description

Off-white powder

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/010

Vitamin K2 (as all-trans MK7) assay

> 0.25% or > 2500ppm

UPLC method*/USP method**
ANL/KJ/010

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/010

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/010

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/010

Particle size

> 90% passes through 40 mesh

PB-264 rev.1*

Bulk density

0.30-0.55 g/ml

Ph. Eur. <2.9.34> / USP <616>

Loss on drying

≤ 5.0%

Ph. Eur. <2.2.32> /USP<713>

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 0.2% Maltodextrin Powder

Ref. no. SPK/KJ/010

Rev. 06

Date: 16.04 .2025

Product name

Pharmaquinone^® 0.2% Maltodextrin Powder Vitamin K2 as MK-7

SKU code

020PM

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

Maltodextrin Powder

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

Maltodextrin

9050-36-6

General information

Synthetic vitamin K2 diluted in oil solution and deposited on the maltodextrin for use in food and dietary supplements

Country of origin

Poland

Shelf-life

30 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. Protect from light. After opening, store in the original closed container.

Packaging

1 kg (020PM1) or 5 kg (020PM5) of the product in doypack with zipper bag

Tests

Requirements

Method

Description

Light yellow powder

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/010

Vitamin K2 (as all-trans MK7) assay

> 0.20% or > 2000ppm

UPLC method*/USP method**
ANL/KJ/010

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/010

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/010

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/010

Particle size

> 90% passes through 30 mesh

PB-264 rev.1*

Bulk density

0.30-0.50 g/ml

Ph. Eur. <2.9.34> / USP <616>

Loss on drying

≤ 6.0%

Ph. Eur. <2.2.32> /USP<713>

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 0.2% MCC Powder

Ref. no. SPK/KJ/005

Rev. 08

Date: 16.04 .2025

Product name

Pharmaquinone^® 0.2% MCC Powder Vitamin K2 as MK-7

SKU code

020P

Active Ingredient

Menaquinone-7 (MK-7)

Carrier

MCC Powder

CAS number

Menaquinone-7

2124-57-4

MCT oil

73398-61-5

MCC powder

9004-34-6

General information

Synthetic vitamin K2 diluted in oil solution and deposited on the microcrystalline cellulose for use in food and dietary supplements

Country of origin

Poland

Shelf-life

36 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. Protect from light. After opening, store in the original closed container.

Packaging

1kg (020P1) or 5 kg (020P5) of the product in doypack with zipper bag

Tests

Requirements

Method

Description

Off-white powder

Visual assessment

Identification
‍HPLC

Corresponds to the standard HPLC profile

UPLC method*/USP method**
ANL/KJ/010

Vitamin K2 (as all-trans MK7) assay

> 0.20% or > 2000ppm

UPLC method*/USP method**
ANL/KJ/010

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/010

Related substances
Single unknown impurity
Total impurities

≤ 1.0%
≤ 1.5%

UPLC method* ANL/KJ/010

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/010

Particle size

> 90% passes through 40 mesh

PB-264 rev.1*

Bulk density

0.30-0.55 g/ml

Ph. Eur. <2.9.34> / USP <616>

Loss on drying

≤ 5.0%

Ph. Eur. <2.2.32> /USP<731>

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 0.3 ppm
≤ 0.5 ppm
≤ 0.1 ppm

PN-EN-15763:2010

Microbiological parameters
TAMC in 1g
TYMC in 1g
E. Coli in 1g
Salmonella in 25g
Staphylococcus aureus in 1g
Bile tolerant gram-negative bacteria in 1g***

≤ 1 x 10³ CFU
≤ 1 x 10² CFU
Absent
Absent
Absent
≤ 1 x 10² CFU

Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.12> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>
Ph. Eur. <2.6.13> / USP <2021>

* in-house method
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** bile tolerant gram-negative bacteria include Enterobacteriaceae, Pseudomonas and Aeromonas

Pharmaquinone^® 99% Active Ingredient

Ref. no. SPK/KJ/001

Rev. 09

Date: 16.04 .2025

Product name

Pharmaquinone^® 99% Active Ingredient Vitamin K2 as MK-7

SKU code

K2MK7

CAS number

2724-57-4

Chemical name

Menaquinone-7 (MK-7)

Structural formula

Molecular formula

C₄₆H₆₄O₂

Formula weight

649,01

Country of origin

Poland

Description

Yellow crystalline powder

Retest date

36 months from manufacture

Storage conditions

The product should be stored at temperature 15-25°C 59-77°F, in a dry place. After opening, store in the original closed container.

Packaging

≤ 1,5 g - Amber glass vials with solid-top screw.
≥ 10 g - HDPE containers (high density polyethylene), light-protective, intended for contact with food.

Tests

Requirements

Method

Description

Yellow crystalline powder

Visual assessment

Identification
‍IR
HPLC

Corresponds to the standard IR spectrum
Corresponds to the standard HPLC profile

IR method*** ANL/KJ/007
UPLC method*/USP method**
ANL/KJ/007

Vitamin K2 (as all-trans MK7) assay (calculated on the as-is basis)

99.0% - 101.0%

UPLC method*/USP method**
ANL/KJ/007

Limit of Menaquinone-6

Absent

UPLC method*/USP method**
ANL/KJ/007

Related substances
Single unknown impurity
Total impurities

≤ 0.5%
≤ 1.0%

UPLC method* ANL/KJ/007

Isomeric purity
Content of cis-menaquinone-7

≤ 1.0%

USP method* ANL/KJ/007

Loss on drying

≤ 0.5%

TGA method*** ANL/KJ/007

Sulphated ash

≤ 0.1%

Ph. Eur. <2.4.14>

Residual solvents
Acetone
Ethyl acetate

≤ 1500 ppm
≤ 500 ppm

GC method**** ANL/KJ/007

Metal content
Arsenic
Cadmium
Lead
Mercury

≤ 0.5 ppm
≤ 1 ppm
≤ 3 ppm
≤ 0.1 ppm

ICP-MS method*** ANL/KJ/007

* in-house UPLC method based on J. Pharm, Biomed. Anal. 135, 116-125
** in accordance with Dietary Supplement Monograph, Menaquinone-7 Preparation, USP-NF
*** in-house method
**** in-house method, validated according to ICH Guideline Q3C(9R) and Q2(R2)

Product Specification

Pharmaquinone® 5% MCT Oil

Pharmaquinone® 1% MCT Oil

Pharmaquinone® 0.45% Olive Oil

Pharmaquinone® 0.15% MCT Oil

Pharmaquinone® 1% MCC Powder

Pharmaquinone® 0.25% MCC Powder

Pharmaquinone® 0.2% Maltodextrin Powder

Pharmaquinone® 0.2% MCC Powder

Pharmaquinone® 99% Active Ingredient

Contact us

Pharmaquinone^® 5% MCT Oil

Pharmaquinone^® 1% MCT Oil

Pharmaquinone^® 0.45% Olive Oil

Pharmaquinone^® 0.15% MCT Oil

Pharmaquinone^® 1% MCC Powder

Pharmaquinone^® 0.25% MCC Powder

Pharmaquinone^® 0.2% Maltodextrin Powder

Pharmaquinone^® 0.2% MCC Powder

Pharmaquinone^® 99% Active Ingredient